Kojima Tomohiro, Ogawa Takumi, Kitao Souichiro, Sato Manabu, Oda Akifumi, Ohta Kiminori, Endo Yasuyuki
Faculty of Pharmaceutical Sciences, Tohoku Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.
Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan; Institute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Bioorg Med Chem. 2015 Nov 1;23(21):6900-11. doi: 10.1016/j.bmc.2015.09.046. Epub 2015 Oct 1.
Monoalkylated bis(4-hydroxyphenyl)methanes (e.g., 1) are reported to show weak binding affinity for estrogen receptor (ER). We hypothesized that introduction of appropriately located hydrophobic substituents in these compounds would increase the binding affinity. Indeed, we found that bis(4-hydroxyphenyl)methane bearing a 3,3-dimethylcyclohexyl group (7) shows potent ERα binding affinity, comparable to that of estradiol. Bulkier substituents could be introduced at the 3,3-position without decreasing the affinity. However, the position of the substituents was critical: the 4,4-dimethylcyclohexyl derivative (2) showed very weak binding affinity. The compounds with high ER-binding affinity showed predominantly agonistic activity, together with weak antagonistic activity at high concentration, in cell proliferation assay with human breast cancer cell line MCF-7. Further structure-function studies of these compounds and their derivatives might lead to the development of more selective and potent estrogen receptor modulators.
据报道,单烷基化双(4-羟基苯基)甲烷(例如1)对雌激素受体(ER)表现出较弱的结合亲和力。我们推测,在这些化合物中引入适当位置的疏水取代基会增加结合亲和力。事实上,我们发现带有3,3-二甲基环己基的双(4-羟基苯基)甲烷(7)表现出强大的ERα结合亲和力,与雌二醇相当。可以在3,3-位引入更大的取代基而不降低亲和力。然而,取代基的位置至关重要:4,4-二甲基环己基衍生物(2)表现出非常弱的结合亲和力。在用人乳腺癌细胞系MCF-7进行的细胞增殖试验中,具有高ER结合亲和力的化合物主要表现出激动活性,在高浓度下还具有弱拮抗活性。对这些化合物及其衍生物进行进一步的结构-功能研究可能会导致开发出更具选择性和效力的雌激素受体调节剂。